Cambridge Trust CO Merck & Co., Inc. Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 338,060 shares of MRK stock, worth $35.4 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
338,060
Previous 235,718
43.42%
Holding current value
$35.4 Million
Previous $25.7 Million
73.59%
% of portfolio
1.72%
Previous 1.09%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,803Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$25.6 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.3 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.6 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.98 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $266B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...